Risacal-D Interactions
There are 285 drugs known to interact with Risacal-D (calcium / vitamin d), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 19 are major, 222 are moderate, and 44 are minor.
- View all 285 medications that may interact with Risacal-D
- View Risacal-D alcohol/food interactions (2)
- View Risacal-D disease interactions (11)
Most frequently checked interactions
View interaction reports for Risacal-D (calcium / vitamin d) and the medicines listed below.
- acarbose
- acetazolamide
- acyclovir
- alendronate
- alfuzosin
- amlodipine
- amoxicillin
- aspirin
- atorvastatin
- atropine ophthalmic
- brimonidine ophthalmic
- brimonidine / timolol ophthalmic
- ciprofloxacin ophthalmic
- clarithromycin
- cyclosporine ophthalmic
- docusate
- dorzolamide ophthalmic
- dorzolamide / timolol ophthalmic
- erythromycin ophthalmic
- Farxiga (dapagliflozin)
- finasteride
- glipizide
- latanoprost ophthalmic
- levocetirizine
- loratadine
- losartan
- lubiprostone
- metformin
- omeprazole
- Vitamin D3 (cholecalciferol)
Risacal-D alcohol/food interactions
There are 2 alcohol/food interactions with Risacal-D (calcium / vitamin d).
Risacal-D disease interactions
There are 11 disease interactions with Risacal-D (calcium / vitamin d) which include:
- cardiovascular adverse effects
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- arrhythmia
- electrolyte imbalance
- hypercalcemia
- renal dysfunction
- hepatobiliary dysfunction
Report options
QR code containing a link to this page
More about Risacal-D (calcium / vitamin d)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.